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A B S T R A C T
Background: Up to 85% of hospital in-patients will require some form of vascular access
device to deliver essential ﬂuids, drug therapy, nutrition and blood products, or facilitate
sampling. The failure rate of these devices is unacceptably high, with 20–69% of peripheral
intravenous catheters and 15–66% of central venous catheters failing due to occlusion,
depending on the device, setting and population. A range of strategies have been
developed to maintain device patency, including intermittent ﬂushing. However, there is
limited evidence informing ﬂushing practice and little is known about the current ﬂushing
practices.
Objective: The aim of the study was to improve our understanding of current ﬂushing
practices for vascular access devices through a survey of practice.
Method: A cross-sectional survey of nurses and midwives working in the State of
Queensland, Australia was conducted using a 25-item electronic survey that was
distributed via the local union membership database.
Results: A total of 1178 surveys were completed and analysed, with n = 1068 reporting
peripheral device ﬂushing and n = 584 reporting central device ﬂushing. The majority of
respondents were registered nurses (55%) caring for adult patients (63%). A large
proportion of respondents (72% for peripheral, 742/1028; 80% for central, 451/566) were
aware of their facility’s policy for vascular access device ﬂushing. Most nurses reported
using sodium chloride 0.9% for ﬂushing both peripheral (96%, 987/1028) and central
devices (75%, 423/566). Some concentration of heparin saline was used by 25% of those
ﬂushing central devices. A 10-mL syringe was used by most respondents for ﬂushing;
however, 24% of respondents used smaller syringes in the peripheral device group. Use of
preﬁlled syringes (either commercially prepared sterile or preﬁlled in the workplace) was
limited to 10% and 11% respectively for each group. The frequency of ﬂushing varied
widely, with the most common response being pro re nata (23% peripheral and 21%
central), or 6 hourly (23% peripheral and 22% central). Approximately half of respondents
stated that there was no medical order or documentation for either peripheral or central
device ﬂushing.
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What is already known about the topic?
 Approximately 85% of all hospitalised patients will
require some form of intravenous therapy.
 Vascular access device occlusion ranges from 15 to 69%
depending on device and setting, with associated costs to
the patient, organisation and healthcare system.
 There is a paucity of research and a high degree of
practice variation in the maintenance of peripheral and
central venous device patency, including the role of
ﬂushing to prevent complications.
What this paper adds
 The results of this study have clariﬁed nursing and
midwifery practice related to vascular access device
ﬂushing.
 The results further highlight the inconsistencies in
ﬂushing practice and the need for evidence in this area.
 The results have laid the foundation for an informed
protocol development for future intervention and
randomised controlled trial work in vascular access
device patency and ﬂushing practice.
1. Introduction and background
Venous access via peripheral and central venous
catheters is frequently used in hospital care to administer
ﬂuids, drugs, blood and nutrition, and to withdraw blood
for testing, among other purposes. These devices may need
to be left in place for days or even weeks; but they are
associated with complications that can be mechanical or
infectious. Mechanical complications include occlusion,
thrombosis, dislodgement, inﬁltration, leakage, phlebitis
and scar formation. Infectious complications include
bacterial or fungal sepsis. Thrombosis or phlebitis at the
catheter site can act as a focus for nosocomial infection that
is associated with extended admission time, additional
costs and increased mortality (Maki et al., 2006; Maki and
Ringer, 1991; Mermel et al., 2009).
Each year, approximately 450,000 individuals are
admitted to Queensland public hospitals (Australian
Bureau of Statistics, 2013). The majority require intrave-
nous catheterisation for the administration of medications
or ﬂuid. Based upon this, it is estimated that 150,000 will
need a peripheral intravenous catheter in place for more
than three days (Tuffaha et al., 2014). A survey from
2003 stated the proportion of central venous catheter use
is approximately 29% of the general hospital population,
rising up to 80% for patients in critical care settings (Climo
et al., 2003). There have been a range of strategies to
prevent or reduce intravenous catheter related complica-
tions. These include: optimising patency through continu-
ous infusion or intermittent ﬂushes with either normal
saline, heparin, antibiotic and/or ethanol locks (Goode
et al., 1991; Peterson and Kirchhoff, 1991; Randolph et al.,
1998); less frequent catheter and infusion set changes
(Bregenzer et al., 1998; Cornely et al., 2002; Homer and
Holmes, 1998; Rickard et al., 2012; White, 2001);
placement of in-line ﬁlters (Chee and Tan, 2002; Roberts
et al., 1994); and designated intravenous therapy teams
(da Silva et al., 2010; Wenzel and Edmond, 2006). Despite
these interventions, catheter failure before the end of
treatment is all too common. The failure rate of peripheral
intravenous catheters due to occlusion is 20–69% (Bolton,
2010; Rickard et al., 2010, 2012; Royer, 2003). The failure
rate of central venous catheters due to occlusion ranges
from 15% to 66%, depending on the device, setting and
population (Baskin et al., 2009; Raad et al., 2002, 2003;
Timsit et al., 2011a). Repeated catheter insertions due to
failed catheters require multiple penetrations of the skin
barrier, increase patient discomfort and staff time, and
predispose patients to infection from skin commensals.
Such infections can be life threatening in the acute and
critically ill (Maki et al., 2006; Mermel et al., 2009; Raad
et al., 2007). Therefore, methods that can prolong the
duration of viability of both peripheral and central venous
catheters hold signiﬁcant beneﬁt for patient outcomes and
the quality of organisational care delivered.
The USA’s Centers for Disease Control (CDC) and the
UK’s EPIC3 Guidelines for preventing healthcare associated
infections (HCAIs) only brieﬂy address the issue of vascular
access device patency, and when they do it is in relation to
central venous catheters not peripheral intravenous
catheters. The Catheter Related Bloodstream Infection
(CRBSI) rate in central venous catheters in the USA is
approximately 3% (Maki et al., 2006) whereas central
venous catheter failure rates due to occlusion or thrombo-
sis range from 15 to 66% (Baskin et al., 2009; Raad et al.,
2003, 2002; Timsit et al., 2011a). CRBSI rates in peripheral
intravenous catheters are extremely low (0.1% Maki et al.,
2006). On the other hand, peripheral intravenous catheter
failure rates due to dislodgement, occlusion, inﬁltration or
phlebitis sit at 26% in Australia (Rickard et al., 2012), 38% in
Spain (Chico-Padron et al., 2011) and 53% in the USA
(Bausone-Gazda et al., 2010). Leading professional Asso-
ciations include some guidelines for maintaining vascular
Conclusions: Flushing practices for vascular access device ﬂushing appear to vary widely.
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access device patency through ﬂushing (Infusion Nurses
Society, 2011; Royal Nurses’ Association of Ontario, 2005).
Levels of evidence informing these recommendations
were limited to level IV or V (i.e. single quasi-experimen-
tal clinical/lab study or clinical opinion). Recommenda-
tions about frequency, volume, syringe size or mode
differed. Local guidelines are found to be similarly lacking
or inconsistent.
The results of research comparing continuous infusion
versus intermittent ﬂushes to maintain catheter patency
remain inconclusive, with studies yielding varied ﬁndings
(Fernandez et al., 2003; Flint et al., 2005). There are no large
multi site trials comparing different ﬂushing regimens (i.e.
regular versus PRN; 6 hourly versus daily; 3 mL versus
10 mL). Evidence about the use of heparinised ﬂushing
solution versus normal saline or other interventions is also
inconclusive (Randolph et al., 1998). Indeed, the optimum
approach to ﬂushing practice is not known, therefore the
inconsistent nature of ﬂushing recommendations in orga-
nisational guidelines is not surprising. Consequently, it is
timely to survey current ﬂushing practice related to
maintenance of peripheral and central venous catheter
patency.
2. Aim and objective of study
The aim of this study was to survey a large cohort of
nurses and midwives with the objective of increasing our
knowledge and understanding of current ﬂushing prac-
tices.
2.1. Design
This study employed a descriptive, exploratory design
using a large cross-sectional survey to gather information
that would address the following research questions:
1. What are the current peripheral intravenous catheter
ﬂushing practices among nurses and midwives in
Queensland hospitals?
2. What are the current central venous catheter ﬂushing
practices among nurses and midwives in Queensland
hospitals?
2.2. Sample
The population of registered nurses and midwives in
Queensland (Australia) hospitals was accessed through the
Queensland Nurses’ Union (QNU) database. There are
approximately 67,000 nurses and midwives registered in
Queensland. Of these 49,806 are QNU members, of whom
approximately 70% receive an electronic newsletter. The
QNU agreed to pass on the survey invitation and link to
these members via the monthly electronic newsletter for
two consecutive months.
2.3. Survey
A literature search identiﬁed a tool developed speciﬁ-
cally for measuring the ﬂushing practices of nurses that
cared for patients who had a central venous catheter
inserted (Sona et al., 2012). This survey was based upon the
original ten-item instrument that was used for a national
survey of critical care nurses drawn from the American
Association of Critical Care Nurses (Sona et al., 2012). The
items and content were based on a literature search that
remains current and had input from clinical experts. The
authors had also tested face and content validity using a
pilot sample and expert panel. Some changes were made to
the original tool for the study conducted in Queensland, in
order to (a) make it applicable to the Australian population
(i.e. vernacular), and (b) be relevant to peripheral
intravenous catheter ﬂushing as well as that of central
venous catheters. The ﬁnal Australian survey had 25 items
(including demographics). The majority of questions
followed a multiple-choice format but did include short
response items. It was designed to take approximately
10 min to complete. The survey was conducted using an
electronic platform with licensed software (LimeSur-
veyTM). All responses were conﬁdential and anonymous.
This survey tool was successfully piloted locally using the
electronic method of delivery before implementation.
2.4. Data collection
Following approval by both hospital and university
based Human Research Ethics Committees (NRS/19/13/
HREC), an invitation to participate in the survey was sent
out for July 2013. A reminder message was sent the
following month in the newsletter to optimise response
rate. Participants were asked to complete the survey on-
line via a web link in the electronically distributed
newsletter.
2.5. Data analysis
Survey data were exported and analysed using PASW
Statistics v.20 (SPSS Inc.). Descriptive statistics were
calculated to summarise demographics and key variables.
Data were presented for the overall sample, and then
broken down into those who reported peripheral intrave-
nous catheter ﬂushing, and those who reported central
venous catheter ﬂushing. There was overlap between the
respondents who replied for the peripheral and central
venous catheter sections of the survey. Cross tabulation
and differences between variables were tested using
Pearson’s chi-square.
3. Results
A total of 1203 surveys were returned, with 1178 con-
taining complete data for further analysis (see Fig. 1). Of
this number, 1068 (91%) respondents cared for patients
with peripheral intravenous catheters and 584 (50%) cared
for patients with central venous catheters. The majority of
respondents were registered nurses (55%) caring for adult
patients (63%) in a metropolitan facility (48%). Respon-
dents represented nurses and midwives from a range of
settings: primary and acute; metropolitan, regional and
remote; neonatal, paediatric, adult. Full occupational
details are presented in Table 1. The broad distribution
of the survey promoted the opportunity to receive
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responses from nurses and midwives working in regional
and rural settings (35% and 17% respectively), as well as
across a range of patient populations including paediatric
and neonatal (7% and 2% respectively). Respondents had a
range of experience but were represented evenly, with 50%
of respondents having worked in their clinical domain for
more than six years.
3.1. Flushing practice
Data revealed that sodium chloride 0.9% was the most
frequent solution used for ﬂushing for both peripheral
catheters (96%) and central catheters (75%) devices. Some
form of Heparin was used by 25% of respondents in the
central venous catheter group. The majority of respon-
dents (approximately 60%) reported 10 mL as the most
common volume used to ﬂush both peripheral and central
venous catheter, with 5 mL being the next most common
amount. Most respondents used a 10 mL size syringe to
administer ﬂushes to peripheral catheters (75%) and
central catheters (82%). Of respondents using syringes of
less than 10 mL volume, there was a higher incidence (23%)
in the peripheral catheter group than the central catheter
group (8%). Cross tabulation and correlation analysis
revealed that clinicians from a paediatric/neonatal setting
were more likely to use a smaller syringe (i.e. 2 mL or 5 mL)
to administer a peripheral intravenous catheter ﬂush than
those working in an adult setting (52% and 89% respec-
tively, p < 0.0001). Responses on frequency of ﬂushing
were wide and varied, with the most commonly reported
timings being pre- and post-drug administration only
(Peripheral 23% and Central 21%), and pre- and post-drug
plus 6 hourly administration (Peripheral 23% and Central
22%). Full details of all responses are in Table 2.
Most nurses and midwives reported being aware of an
institutional ﬂushing policy related to peripheral and
central venous catheters (72% and 80% respectively). The
vast majority of respondents manually prepared ﬂushes
for administration, with only a small percentage using
preﬁlled syringes (Peripheral 10% and Central 11%). It is
unknown whether these respondents were referring to
commercially available, sterile pre-ﬁlled ﬂush syringes, or
to manually pre-ﬁlled syringes by themselves or another
practitioner in their institution. Less than half of the
respondents in both groups reported that a medical order
was required for ﬂushing. Chi square testing revealed that
nurses from a paediatric or neonatal setting were more
likely to have an order for ﬂushing and to document
administration of ﬂush, compared with practices in adult
settings (Peripheral 89% and 82% respectively, p < 0.001,
* PIVC – peripheral intravenous cath eter ** Central venous catheter 
n=1178 
Use CVC **584  
Total number  of  re sponses 
(n=1203) 
Incomplete 
demographics  (n=25) 
Use PIVC* 1028 
Union eNews recipients 
n=34,864 (approx  70%) 
Union members 
n=49,806 
Queensland Nurse’s & Midwives 
n=66,364 
Fig. 1. Sample ﬂow diagram.
S. Keogh et al. / International Journal of Nursing Studies 52 (2015) 1678–1685 1681
and Central 84% and 66% respectively, p < 0.001). More
than half reported that they document ﬂush administra-
tion in either the medication chart or ﬂuid balance chart.
A third of all respondents reported that their ﬂush
administrations were rarely documented. Details of these
characteristics are presented in Table 3.
4. Discussion
The study achieved its aim to generate a cross-sectional
snapshot of nursing and midwifery vascular access device
ﬂushing practice across Queensland. This is the ﬁrst
systematic investigation undertaken into peripheral intra-
venous catheter ﬂushing practice anywhere in the world,
and only the second study to our knowledge focussing on
central venous catheters. Like Sona and colleagues’ work
from the USA, we found a wide variation in practitioners’
responses for ﬂushing solution, frequency and volumes.
Their respondents reported a slightly higher use of heparin
solution for central venous catheter ﬂushing (33%, 213/
632) compared to our ﬁnding of 25%, and reported eight
hourly standardised ﬂushing as the most common practice,
compared to our ﬁnding of six hourly plus pre/post-drug
administration.
Most respondents in this study reported that their
standard ﬂush solution was sodium chloride 0.9% using
10 mL of solution in a 10 mL syringe. Paediatric and
neonatal practitioners were more likely to use smaller
syringes. Flushing syringes chosen were either 2 mL or
5 mL sizes for 89% of neonatal nurses and 54% of paediatric
nurses. This is probably related to the general use of
smaller volumes for ﬂushing in these populations. This
implies a lack of appreciation for the increase in pressure
per square inch (PSI) associated with the properties of
smaller size syringes. The use of reduced pressure for ﬂush
delivery through a syringe with a larger gauge such as the
standard 10 mL syringe is recommended to optimise ﬂush
outcomes and minimise damage to the vein (Hadaway,
2006; Macklin, 1999; Perucca, 2010). These recommenda-
tions are largely derived from physics principles, and have
not been and possibly could not be explicitly tested in
clinical trials. In recent times, commercially prepared
preﬁlled ﬂush syringes have become available, which
negate the potential for operators to make an incorrect
choice of a smaller size syringe, since they are produced in
diameters consistent with a 10 mL syringe, but in 3, 5 and
10 mL volumes. A small, single site trial of different
ﬂushing frequencies (twice daily versus once daily)
demonstrated similar risk of peripheral intravenous
catheter failure (12.1% versus 9.5%). However, the sample
was a select paediatric population (no infusion therapy or
intravenous antibiotics). Additionally, the overall risk of
failure was noted to be very low compared to other studies
(8.7%, n = 497) and this was possibly related to the use of
pre-ﬁlled ﬂush syringes across both groups (Schreiber
et al., 2015). One non-randomised study suggests pre-ﬁlled
ﬂush syringes can reduce bloodstream infections, over
manually ﬁlled syringes (Bertoglio et al., 2013).
Table 1
Occupational proﬁle of nursing and midwifery respondents.
Overall
n = 1178
PIVCa
n = 1068
CVCb
n = 584
Hospital type
Metropolitan 562 (48%) 523 (49%) 336 (57%)
Regional 414 (35%) 375 (35%) 202 (35%)
Rural/remote 202 (17%) 170 (16%) 46 (8%)
Patient type
Adult 743 (63%) 670 (63%) 392 (67%)
Combined 329 (28%) 293 (27.4%) 124 (21%)
Paediatric 77 (7%) 76 (7.1%) 59 (10%)
Neonatal 29 (2%) 29 (3%) 9 (2%)
Position
RN 651 (55%) 602 (56%) 352 (60%)
CN 317 (27%) 297 (28%) 169 (29%)
CNC/NUM 89 (8%) 74 (7%) 42 (7%)
Midwife 59 (5%) 51 (5%) 7 (1%)
EEN 44 (4%) 32 (3%) 8 (1%)
Level 8+ 14 (1%) 11 (1%) 5 (1%)
EN 4 (0.3%) 1 (0.1%) 1 (0.2%)
Years in nursing
<2 years 236 (20%) 210 (20%) 100 (17%)
2–5 years 362 (31%) 332 (30%) 181 (31%)
6–10 years 231 (19%) 211 (20%) 122 (21%)
>10 years 349 (30%) 315 (30%) 181 (31%)
a PIVC – peripheral intravenous catheter.
b Central venous catheter.
Table 2
Data on IVD ﬂushing practice from nursing and midwifery respondents.
PIVCa
n = 1068
CVCb
n = 584
Flush solution
NaCl 0.9% 987 (96%) 423 (75%)
HepSaline 33 (3%) 102 (18%)
Other 8 (1%) 41 (7%)
Incomplete/missing data 40 (4%) 18 (3%)
Flush volume
2 mL 55 (5%) 23 (4%)
5 mL 324 (31%) 104 (18%)
10 mL 589 (57%) 348 (61%)
20 mL – 40 (7%)
Other 60 (%) 51 (10%)
Incomplete/missing data 40 (4%) 18 (3)
Syringe size
2 mL 40 (4%) 12 (2%)
5 mL 192 (19%) 37 (7%)
10 mL 768 (75%) 465 (82%)
20 mL – 34 (6%)
Other 28 (2%) 18 (3%)
Incomplete/missing data 40 (4%) 18 (3%)
Frequency of ﬂush
Pre/post drug admin only 237 (23%) 117 (21%)
4/24 only 45 (4%) 18 (3%)
4/24 + pre/post drug admin 94 (9%) 52 (9%)
6/24 only 139 (13%) 65 (11%)
6/24 + pre/post drug admin 238 (23%) 126 (22%)
8/24 only 69 (7%) 28 (5%)
8/24 + pre/post drug admin 129 (13%) 66 (12%)
Daily only 26 (2%) 18 (3%)
Daily + pre/post drug admin 51 (5%) 76 (14%)
Incomplete/missing data 40 (4%) 18 (3%)
a PIVC – peripheral intravenous catheter.
b Central venous catheter.
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Reported use of preﬁlled syringes by participants was
minimal in this survey (Peripheral 10% and Central 11%).
We did not ask respondents who was pre-ﬁlling the
syringes, which may have been manufacturer-prepared
sterile syringes which are clearly labelled as to contents
and with 10 mL diameters, or syringes pre-prepared by
the nurse/midwife themselves, or by another colleague.
The latter practice would be concerning due to the risk of
microbial contamination and potential lack of labelling.
A small but substantial number of practitioners caring
for central venous catheters (25%) reported using some
form of Heparin as a ﬂush solution. The reason for this is
not known. Currently the Queensland State policy for
central venous catheter ﬂushing recommends Sodium
Chloride 0.9% as the preferred ﬂush or infusion solution
(Queensland Health, 2011). A number of studies have
shown Heparin to support the growth of organisms in
solution and in bioﬁlm (Raad et al., 2002, 2003; Shah et al.,
2002; Shanks et al., 2005). Both experimental and cohort
studies suggest a close relationship between catheter
thrombosis and infection, indicating a need for Heparin
(Timsit et al., 2011a,b). Other clinical trial results
demonstrated that Heparin might reduce CRBSI (Abdelkeﬁ
et al., 2005; Birch et al., 2010; Pierce et al., 2000). The latter
studies reported that the Heparin solution also contained a
preservative with antimicrobial activity, and it is therefore
unclear whether the decrease in CRBSI rate would be due
to decreased thrombus formation or the preservative, or
both (Timsit et al., 2011a). The potential beneﬁts of
Heparin ﬂushes and/Heparin-coated catheters must be
balanced against the risk of Heparin-induced thrombocy-
topenia, a rare but serious adverse reaction (Timsit et al.,
2011b).
There is currently little evidence informing the
recommendations for either the volume or frequency
required for a vascular access device ﬂush. Generally,
organisational and industry guidelines recommend ‘‘a
minimum ﬂush volume equal to twice the internal volume
of the catheter system, which includes the catheter,
extension set, and/or needleless injection system added
to the catheter hub’’ (Infusion Nursing Society, 2011). This
usually translates to 1–3 mL for a peripheral intravenous
catheter and 5–10 mL for central venous catheter, with a
volume of 20 mL preferred after obtaining a blood sample
(Infusion Nursing Society, 2011). Such recommendations
were generally reﬂected in the practice reported by
participants for central venous catheters, but ﬂush
volumes larger than 3 mL were commonly reported for
peripheral intravenous catheters in this survey, suggesting
a widespread lack of knowledge of these recommendations
for these devices. Similar to lack of recommendations
regarding ﬂush volumes, there are few studies evaluating
the effect of ﬂushing frequency on patient outcomes, with
no rigorous trials to inform practice for either of these two
variables (Campbell et al., 2005). This lack of evidence to
inform clinicians was apparent from the survey results,
which revealed an unacceptable variation in the array of
ﬂushing practices amongst respondents caring for patients
with these devices.
Respondents in this study were largely aware of their
local Queensland Health policy on vascular access device
ﬂushing (Peripheral 72% and Central 80%). The policy
allows for nurse-initiated ﬂushing without a speciﬁc
medical order, but there is no recommendation for
documentation of these ﬂushes, and respondents reported
poor and varied documentation of ﬂushing. A record of
vascular access device ﬂushes given would not only
demonstrate the evaluation and conﬁrmation of device
assessment and patency but also record the patient’s ﬂuid
balance. An exception was noted, in that respondents from
paediatric or neonatal settings were more likely to
document ﬂush administration. This reﬂects the practice
of maintaining a strict ﬂuid balance record in these
settings.
This study has principally highlighted and conﬁrmed
the variation and gaps in vascular access device ﬂushing
practice and knowledge. In lieu of much needed trial
research, clinicians and organisations could make efforts to
standardise and streamline ﬂushing practice in order to
minimise inconsistencies and optimise documentation.
The USA’s Infusion Nursing Society, Canada’s Registered
Nurses’ Association Ontario, and many local guidelines
recommend: initial aspiration of blood to ascertain
vascular access device patency; a minimum of pre- and
post-drug administration ﬂushing; use of single dose
preﬁlled ﬂush syringes to minimise device and solution
contamination and incorrect syringe use; volume deter-
mined by size of catheter and patient; and use of a pulsatile
technique (Infusion Nursing Society, 2011; Registered
Nurses’ Association Ontario, 2005).
The strengths of this study were its large number of
respondents and grounding in the current literature.
Generalisability of results is somewhat limited, since the
respondents did not include the total workforce of the
State of Queensland. Nonetheless, the large absolute
numbers and heterogeneous sample does suggest that a
Table 3
Data on organisational recommendations and ﬂushing practice from
nursing and midwifery respondents.
PIVCa
n = 1068
CVCb
n = 584
Flushing policy
Yes 742 (72%) 451 (80%)
No 82 (8%) 28 (5%)
Unsure 204 (19%) 87 (15%)
Incomplete/missing 40 (4%) 18 (3%)
Preparation
Manual 915 (89%) 501 (88%)
Preﬁlled 108 (10%) 64 (11%)
Incomplete/missing data 45 (4%) 19 (3%)
Flush order
Yes 396 (38%) 267 (47%)
No 598 (58%) 273 (48%)
Unsure 30 (3%) 24 (5%)
Incomplete/missing data 44 (4%) 20 (3%)
Flush documented
Medication chart 469 (46%) 282 (50%)
IV Fluid chart 86 (8%) 65 (11%)
Not documented 357 (35%) 164 (29%)
Incomplete/missing data 146 (14%) 75 (12%)
a PIVC – peripheral intravenous catheter.
b Central venous catheter.
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reasonably representative cross-section of this group was
sampled. The absolute denominator is not available, but
based on the population details, the approximate response
rate was 3.5%. Furthermore, observational designs like
cross-sectional studies cannot test any direct cause and
effect relationship and therefore cannot inform or make
ﬁrm recommendations for practice. Although cross-sec-
tional designs provide only a ‘‘once off’’ measurement and
do not allow for understanding of changes in practice over
time, this survey could be repeated some years in the
future to assess for practice evolution. The value of the
study’s results lies in the summary of current practice
and its ability to inform future trial work to improve
ﬂushing practice and patient care.
5. Conclusion
This survey highlights a number of inconsistencies in
practice that reﬂect the current lack of evidence in the area
of vascular access device ﬂushing. Results of the survey
have clariﬁed current nursing practice related to periph-
eral central venous ﬂushing. The study has helped to
identify gaps in practice and research, and lay foundations
for the conduct of randomised controlled trials to generate
evidence related to peripheral central venous ﬂushing.
Rigorous research is urgently required to establish the
optimal ﬂushing solution, volume, frequency, and mecha-
nism that will prevent vascular access device malfunction,
thus optimising patient comfort and clinical outcomes.
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